Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Readmission | 36 | 2023 | 3288 | 5.060 |
Why?
|
Myocardial Infarction | 39 | 2024 | 11519 | 3.910 |
Why?
|
Referral and Consultation | 12 | 2024 | 3620 | 2.250 |
Why?
|
Cardiology | 8 | 2021 | 1702 | 1.990 |
Why?
|
Medicare | 22 | 2024 | 6809 | 1.580 |
Why?
|
Heart Valve Diseases | 6 | 2020 | 1030 | 1.470 |
Why?
|
Patient Discharge | 15 | 2023 | 3479 | 1.440 |
Why?
|
Echocardiography | 9 | 2024 | 5047 | 1.390 |
Why?
|
Heart Failure | 19 | 2024 | 11879 | 1.380 |
Why?
|
Burnout, Professional | 4 | 2023 | 711 | 1.360 |
Why?
|
Remote Consultation | 3 | 2016 | 242 | 1.250 |
Why?
|
International Classification of Diseases | 5 | 2021 | 937 | 1.180 |
Why?
|
Delivery of Health Care, Integrated | 4 | 2020 | 951 | 1.140 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2022 | 362 | 1.130 |
Why?
|
Healthcare Disparities | 6 | 2021 | 3415 | 1.080 |
Why?
|
Uncertainty | 5 | 2022 | 769 | 1.070 |
Why?
|
Ambulatory Care | 6 | 2021 | 2783 | 1.050 |
Why?
|
Decision Support Techniques | 6 | 2021 | 2008 | 1.030 |
Why?
|
Acute Coronary Syndrome | 7 | 2022 | 2194 | 1.030 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2024 | 1566 | 1.020 |
Why?
|
Hospital Costs | 6 | 2021 | 957 | 1.000 |
Why?
|
Quality Indicators, Health Care | 5 | 2020 | 1805 | 0.990 |
Why?
|
Telemedicine | 7 | 2022 | 3109 | 0.960 |
Why?
|
Patient Protection and Affordable Care Act | 6 | 2023 | 1188 | 0.950 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2023 | 42 | 0.950 |
Why?
|
Medicaid | 8 | 2023 | 2840 | 0.940 |
Why?
|
United States | 66 | 2024 | 73039 | 0.930 |
Why?
|
Politics | 3 | 2021 | 822 | 0.890 |
Why?
|
Aortic Valve | 4 | 2024 | 1970 | 0.880 |
Why?
|
Chest Pain | 7 | 2022 | 1101 | 0.850 |
Why?
|
Aortic Valve Stenosis | 4 | 2024 | 2032 | 0.820 |
Why?
|
Humans | 158 | 2024 | 768171 | 0.820 |
Why?
|
Coronary Angiography | 9 | 2024 | 4541 | 0.800 |
Why?
|
Coronary Artery Disease | 10 | 2024 | 6568 | 0.780 |
Why?
|
Angina Pectoris | 4 | 2021 | 957 | 0.770 |
Why?
|
Quality Improvement | 6 | 2020 | 3857 | 0.740 |
Why?
|
Physicians | 5 | 2024 | 4598 | 0.730 |
Why?
|
Hospitalization | 16 | 2023 | 10840 | 0.710 |
Why?
|
American Heart Association | 3 | 2023 | 1050 | 0.710 |
Why?
|
Urinary Bladder, Overactive | 1 | 2022 | 117 | 0.710 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15662 | 0.690 |
Why?
|
Risk Assessment | 16 | 2023 | 24318 | 0.690 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.680 |
Why?
|
Insurance Coverage | 5 | 2023 | 1946 | 0.670 |
Why?
|
General Practitioners | 1 | 2021 | 103 | 0.670 |
Why?
|
Cost Savings | 5 | 2019 | 904 | 0.660 |
Why?
|
Hospitals | 10 | 2023 | 3886 | 0.660 |
Why?
|
Tricuspid Valve | 2 | 2019 | 419 | 0.650 |
Why?
|
Practice Management | 1 | 2019 | 37 | 0.650 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.630 |
Why?
|
Foreign Medical Graduates | 1 | 2019 | 76 | 0.620 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 242 | 0.620 |
Why?
|
Aged | 58 | 2024 | 171502 | 0.610 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 5176 | 0.600 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 856 | 0.600 |
Why?
|
Male | 77 | 2024 | 364731 | 0.590 |
Why?
|
Urinary Incontinence | 1 | 2022 | 490 | 0.580 |
Why?
|
Physicians, Primary Care | 2 | 2022 | 624 | 0.580 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2018 | 388 | 0.580 |
Why?
|
Female | 76 | 2024 | 397187 | 0.570 |
Why?
|
Public Health | 3 | 2021 | 2679 | 0.570 |
Why?
|
Diffusion of Innovation | 1 | 2022 | 724 | 0.570 |
Why?
|
Delivery of Health Care | 7 | 2022 | 5367 | 0.570 |
Why?
|
Mitral Valve Insufficiency | 4 | 2022 | 1415 | 0.560 |
Why?
|
Office Visits | 3 | 2015 | 595 | 0.560 |
Why?
|
Heart Injuries | 1 | 2019 | 207 | 0.560 |
Why?
|
Episode of Care | 1 | 2018 | 127 | 0.560 |
Why?
|
Aged, 80 and over | 29 | 2024 | 59626 | 0.560 |
Why?
|
Hospital Records | 1 | 2017 | 93 | 0.560 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2023 | 1334 | 0.560 |
Why?
|
Health Services Misuse | 1 | 2019 | 246 | 0.550 |
Why?
|
Emergency Service, Hospital | 9 | 2021 | 7951 | 0.550 |
Why?
|
Length of Stay | 10 | 2021 | 6498 | 0.540 |
Why?
|
Defibrillators, Implantable | 2 | 2023 | 1498 | 0.540 |
Why?
|
Benchmarking | 2 | 2020 | 1057 | 0.540 |
Why?
|
Morphine | 2 | 2017 | 658 | 0.540 |
Why?
|
Poverty | 4 | 2023 | 2720 | 0.520 |
Why?
|
Troponin T | 1 | 2021 | 787 | 0.520 |
Why?
|
Diagnostic Errors | 2 | 2024 | 1281 | 0.520 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3941 | 0.520 |
Why?
|
Patient Care Management | 1 | 2019 | 303 | 0.520 |
Why?
|
Neprilysin | 1 | 2019 | 487 | 0.510 |
Why?
|
Islam | 1 | 2016 | 72 | 0.510 |
Why?
|
Health Care Costs | 7 | 2023 | 3239 | 0.510 |
Why?
|
Subacute Care | 1 | 2018 | 187 | 0.510 |
Why?
|
Patient Identification Systems | 1 | 2016 | 75 | 0.500 |
Why?
|
Consumer Health Information | 1 | 2018 | 215 | 0.500 |
Why?
|
Reimbursement, Incentive | 2 | 2018 | 541 | 0.500 |
Why?
|
Patient Admission | 2 | 2020 | 1365 | 0.490 |
Why?
|
Registries | 8 | 2022 | 8375 | 0.490 |
Why?
|
Endocarditis | 1 | 2019 | 352 | 0.480 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 2176 | 0.480 |
Why?
|
Hyperlipidemias | 1 | 2019 | 772 | 0.470 |
Why?
|
Health Status Indicators | 1 | 2020 | 969 | 0.470 |
Why?
|
Stroke Volume | 5 | 2024 | 5622 | 0.470 |
Why?
|
Risk Adjustment | 1 | 2018 | 599 | 0.470 |
Why?
|
Middle Aged | 49 | 2024 | 223487 | 0.460 |
Why?
|
Parenting | 1 | 2020 | 708 | 0.450 |
Why?
|
Program Evaluation | 7 | 2020 | 2507 | 0.450 |
Why?
|
Physicians, Women | 1 | 2020 | 517 | 0.450 |
Why?
|
Drug Costs | 1 | 2022 | 1195 | 0.450 |
Why?
|
Policy Making | 1 | 2018 | 546 | 0.450 |
Why?
|
Myocardial Ischemia | 2 | 2022 | 2138 | 0.450 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 412 | 0.450 |
Why?
|
Electronic Health Records | 5 | 2022 | 4887 | 0.440 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 697 | 0.440 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 809 | 0.440 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15949 | 0.430 |
Why?
|
Survival Rate | 6 | 2021 | 12840 | 0.420 |
Why?
|
Massachusetts | 7 | 2023 | 8890 | 0.410 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1397 | 0.410 |
Why?
|
Exercise Test | 2 | 2018 | 2186 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.410 |
Why?
|
Postoperative Complications | 8 | 2024 | 15833 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3238 | 0.400 |
Why?
|
Practice Guidelines as Topic | 6 | 2019 | 7454 | 0.400 |
Why?
|
Social Responsibility | 1 | 2015 | 382 | 0.400 |
Why?
|
Patient Care Team | 2 | 2020 | 2523 | 0.390 |
Why?
|
Medical Errors | 1 | 2020 | 1260 | 0.390 |
Why?
|
Income | 2 | 2021 | 1878 | 0.390 |
Why?
|
Propensity Score | 2 | 2019 | 1969 | 0.390 |
Why?
|
Internal Medicine | 1 | 2019 | 1064 | 0.390 |
Why?
|
Patient Participation | 2 | 2020 | 1447 | 0.380 |
Why?
|
Caregivers | 1 | 2024 | 2302 | 0.380 |
Why?
|
Time Factors | 15 | 2021 | 40220 | 0.370 |
Why?
|
Risk Factors | 22 | 2023 | 74944 | 0.370 |
Why?
|
Sex Factors | 4 | 2019 | 10632 | 0.360 |
Why?
|
Retrospective Studies | 30 | 2024 | 81760 | 0.360 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 937 | 0.360 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1135 | 0.350 |
Why?
|
Inpatients | 3 | 2021 | 2566 | 0.350 |
Why?
|
Fasting | 1 | 2016 | 1610 | 0.350 |
Why?
|
Endocrinology | 1 | 2016 | 443 | 0.350 |
Why?
|
Thoracic Surgery | 2 | 2024 | 727 | 0.350 |
Why?
|
Mitral Valve | 2 | 2021 | 1475 | 0.340 |
Why?
|
Outpatients | 4 | 2021 | 1600 | 0.340 |
Why?
|
Disclosure | 1 | 2015 | 755 | 0.320 |
Why?
|
Predictive Value of Tests | 8 | 2024 | 15453 | 0.320 |
Why?
|
Health Services Accessibility | 4 | 2023 | 5520 | 0.320 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1468 | 0.320 |
Why?
|
Electric Countershock | 3 | 2021 | 534 | 0.310 |
Why?
|
Job Satisfaction | 2 | 2023 | 548 | 0.300 |
Why?
|
Heart Diseases | 2 | 2019 | 2819 | 0.300 |
Why?
|
Kidney Diseases | 1 | 2019 | 2100 | 0.290 |
Why?
|
Anticoagulants | 5 | 2023 | 4850 | 0.290 |
Why?
|
Pneumonia | 5 | 2019 | 2163 | 0.280 |
Why?
|
Pilot Projects | 5 | 2022 | 8741 | 0.280 |
Why?
|
New England | 2 | 2024 | 1058 | 0.280 |
Why?
|
Vascular Diseases | 1 | 2015 | 1162 | 0.280 |
Why?
|
Primary Prevention | 1 | 2014 | 1188 | 0.270 |
Why?
|
Stroke | 5 | 2022 | 9755 | 0.270 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2017 | 2145 | 0.270 |
Why?
|
Cardiac Surgical Procedures | 2 | 2019 | 3684 | 0.260 |
Why?
|
Treatment Outcome | 19 | 2022 | 65379 | 0.250 |
Why?
|
Algorithms | 4 | 2024 | 14164 | 0.250 |
Why?
|
Coronary Vessels | 2 | 2024 | 3124 | 0.250 |
Why?
|
Patient Preference | 3 | 2018 | 946 | 0.250 |
Why?
|
Quality of Health Care | 3 | 2023 | 4310 | 0.240 |
Why?
|
Forecasting | 3 | 2019 | 2945 | 0.240 |
Why?
|
Comorbidity | 6 | 2024 | 10590 | 0.240 |
Why?
|
Databases, Factual | 8 | 2024 | 8080 | 0.240 |
Why?
|
Stress, Psychological | 2 | 2019 | 4530 | 0.240 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.240 |
Why?
|
Attitude of Health Personnel | 4 | 2024 | 3929 | 0.240 |
Why?
|
Prognosis | 8 | 2019 | 30009 | 0.230 |
Why?
|
Natural Language Processing | 2 | 2024 | 1203 | 0.230 |
Why?
|
Fee-for-Service Plans | 2 | 2019 | 713 | 0.230 |
Why?
|
Guideline Adherence | 3 | 2019 | 2235 | 0.230 |
Why?
|
Minority Groups | 2 | 2018 | 1216 | 0.230 |
Why?
|
Survival Analysis | 4 | 2019 | 10099 | 0.220 |
Why?
|
Aortic Valve Insufficiency | 2 | 2018 | 577 | 0.220 |
Why?
|
Continuity of Patient Care | 2 | 2021 | 1078 | 0.220 |
Why?
|
Mentors | 1 | 2009 | 671 | 0.210 |
Why?
|
Self Care | 2 | 2020 | 799 | 0.210 |
Why?
|
Decision Making | 1 | 2017 | 3953 | 0.210 |
Why?
|
Odds Ratio | 5 | 2018 | 9669 | 0.210 |
Why?
|
Biomedical Research | 1 | 2018 | 3463 | 0.200 |
Why?
|
Population Groups | 1 | 2023 | 209 | 0.200 |
Why?
|
Boston | 4 | 2024 | 9374 | 0.200 |
Why?
|
Cost-Benefit Analysis | 5 | 2022 | 5536 | 0.200 |
Why?
|
Hospital Mortality | 5 | 2021 | 5349 | 0.200 |
Why?
|
Hospitals, General | 2 | 2017 | 809 | 0.190 |
Why?
|
Veterans | 1 | 2016 | 2669 | 0.190 |
Why?
|
Physician-Patient Relations | 3 | 2021 | 3269 | 0.190 |
Why?
|
Triage | 2 | 2020 | 997 | 0.190 |
Why?
|
Policy | 2 | 2023 | 513 | 0.190 |
Why?
|
Subtilisins | 1 | 2021 | 80 | 0.190 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2024 | 374 | 0.190 |
Why?
|
Troponin | 2 | 2022 | 535 | 0.180 |
Why?
|
Health Care Reform | 2 | 2021 | 1256 | 0.180 |
Why?
|
Brugada Syndrome | 1 | 2021 | 98 | 0.170 |
Why?
|
Coronary Disease | 1 | 2014 | 5919 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2024 | 1942 | 0.170 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 346 | 0.160 |
Why?
|
Academic Medical Centers | 3 | 2022 | 2785 | 0.160 |
Why?
|
Electronics, Medical | 1 | 2019 | 72 | 0.160 |
Why?
|
Economics, Hospital | 2 | 2018 | 208 | 0.160 |
Why?
|
Cardiac Tamponade | 1 | 2020 | 175 | 0.160 |
Why?
|
Diagnosis-Related Groups | 1 | 2020 | 445 | 0.160 |
Why?
|
Cause of Death | 2 | 2020 | 3721 | 0.160 |
Why?
|
Pericarditis | 1 | 2020 | 136 | 0.160 |
Why?
|
Observer Variation | 2 | 2015 | 2621 | 0.160 |
Why?
|
Warfarin | 3 | 2023 | 1493 | 0.160 |
Why?
|
Incidence | 7 | 2021 | 21538 | 0.150 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 249 | 0.150 |
Why?
|
Feasibility Studies | 3 | 2020 | 5315 | 0.150 |
Why?
|
Social Values | 1 | 2019 | 224 | 0.150 |
Why?
|
Pericardial Effusion | 1 | 2020 | 246 | 0.150 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39354 | 0.150 |
Why?
|
Logistic Models | 4 | 2023 | 13290 | 0.150 |
Why?
|
Aorta, Thoracic | 1 | 2024 | 1112 | 0.150 |
Why?
|
Dyslipidemias | 2 | 2022 | 873 | 0.150 |
Why?
|
Climate Change | 1 | 2024 | 509 | 0.150 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.140 |
Why?
|
Coronary Stenosis | 1 | 2023 | 802 | 0.140 |
Why?
|
Pandemics | 4 | 2021 | 8747 | 0.140 |
Why?
|
Cohort Studies | 6 | 2022 | 41753 | 0.140 |
Why?
|
General Surgery | 1 | 2009 | 1720 | 0.140 |
Why?
|
Mandatory Reporting | 1 | 2018 | 123 | 0.140 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.140 |
Why?
|
Age Factors | 3 | 2021 | 18415 | 0.140 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 670 | 0.140 |
Why?
|
Ownership | 1 | 2019 | 338 | 0.140 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.140 |
Why?
|
Health Policy | 2 | 2020 | 2697 | 0.140 |
Why?
|
Clinical Coding | 1 | 2018 | 188 | 0.140 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.130 |
Why?
|
Respiratory Tract Diseases | 1 | 2022 | 744 | 0.130 |
Why?
|
Critical Pathways | 2 | 2019 | 476 | 0.130 |
Why?
|
Substance Abuse, Intravenous | 2 | 2019 | 530 | 0.130 |
Why?
|
History, 21st Century | 2 | 2015 | 1573 | 0.130 |
Why?
|
Mortality | 4 | 2020 | 2911 | 0.130 |
Why?
|
Nitrates | 1 | 2017 | 260 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 775 | 0.120 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 898 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1474 | 0.120 |
Why?
|
Program Development | 2 | 2019 | 1300 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 893 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1254 | 0.120 |
Why?
|
Insurance, Health | 3 | 2021 | 2517 | 0.120 |
Why?
|
Risk Reduction Behavior | 2 | 2022 | 1119 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 937 | 0.120 |
Why?
|
Bayes Theorem | 2 | 2022 | 2359 | 0.120 |
Why?
|
Principal Component Analysis | 1 | 2017 | 948 | 0.120 |
Why?
|
History, 20th Century | 2 | 2015 | 2766 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26379 | 0.110 |
Why?
|
Social Class | 2 | 2022 | 2008 | 0.110 |
Why?
|
Morbidity | 2 | 2017 | 1755 | 0.110 |
Why?
|
Medical Records | 2 | 2018 | 1410 | 0.110 |
Why?
|
Canada | 1 | 2019 | 2130 | 0.110 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 418 | 0.110 |
Why?
|
Consensus | 1 | 2023 | 3211 | 0.110 |
Why?
|
Government Regulation | 1 | 2018 | 525 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20762 | 0.110 |
Why?
|
Students, Medical | 1 | 2006 | 1964 | 0.110 |
Why?
|
Discriminant Analysis | 1 | 2013 | 222 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1514 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10397 | 0.110 |
Why?
|
Coronary Artery Bypass | 2 | 2021 | 2191 | 0.110 |
Why?
|
Hypertension | 2 | 2023 | 8616 | 0.100 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 419 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2017 | 990 | 0.100 |
Why?
|
Coronary Care Units | 1 | 2014 | 235 | 0.100 |
Why?
|
Health Literacy | 1 | 2018 | 466 | 0.100 |
Why?
|
Emergency Medicine | 2 | 2019 | 1223 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1551 | 0.100 |
Why?
|
Vaccination | 1 | 2004 | 3437 | 0.100 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2018 | 672 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 945 | 0.100 |
Why?
|
Gastroenterology | 1 | 2018 | 593 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1524 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20225 | 0.090 |
Why?
|
Amygdala | 1 | 2019 | 1379 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2017 | 3837 | 0.090 |
Why?
|
Prospective Studies | 6 | 2023 | 54924 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2018 | 2741 | 0.090 |
Why?
|
Self Report | 1 | 2022 | 3773 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2271 | 0.090 |
Why?
|
Drug Hypersensitivity | 1 | 2019 | 923 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2023 | 14783 | 0.090 |
Why?
|
Particulate Matter | 1 | 2022 | 2617 | 0.090 |
Why?
|
Motivation | 1 | 2020 | 2020 | 0.080 |
Why?
|
Myocardial Revascularization | 1 | 2014 | 795 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1444 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1205 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2019 | 2118 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3447 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4055 | 0.080 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1304 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 840 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1947 | 0.080 |
Why?
|
Prevalence | 3 | 2022 | 15869 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1178 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12543 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1662 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3007 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7243 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14729 | 0.070 |
Why?
|
Regression Analysis | 1 | 2017 | 6340 | 0.070 |
Why?
|
Adult | 11 | 2024 | 223646 | 0.070 |
Why?
|
Paresthesia | 1 | 2008 | 160 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2434 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7852 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5884 | 0.070 |
Why?
|
Reoperation | 2 | 2016 | 4329 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2022 | 4543 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5891 | 0.070 |
Why?
|
Obesity | 3 | 2024 | 13091 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2337 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3433 | 0.060 |
Why?
|
Data Collection | 1 | 2015 | 3326 | 0.060 |
Why?
|
Risk | 1 | 2018 | 9613 | 0.060 |
Why?
|
Electrocardiography | 2 | 2021 | 6412 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2535 | 0.060 |
Why?
|
Health Expenditures | 1 | 2018 | 2389 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2496 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4746 | 0.060 |
Why?
|
Quality of Life | 3 | 2023 | 13490 | 0.060 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2024 | 82 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6209 | 0.060 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2004 | 71 | 0.060 |
Why?
|
Diuresis | 1 | 2023 | 107 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2016 | 1882 | 0.050 |
Why?
|
Food Handling | 1 | 2023 | 158 | 0.050 |
Why?
|
Asthma | 1 | 2022 | 6291 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.050 |
Why?
|
Hematocrit | 1 | 2024 | 623 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2016 | 2780 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3490 | 0.050 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 1667 | 0.050 |
Why?
|
Denmark | 1 | 2004 | 776 | 0.050 |
Why?
|
Fast Foods | 1 | 2023 | 220 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 198 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3533 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22290 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 638 | 0.050 |
Why?
|
Benzylamines | 1 | 2022 | 251 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 247 | 0.040 |
Why?
|
Uracil | 1 | 2022 | 210 | 0.040 |
Why?
|
Ambulances | 1 | 2021 | 94 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9384 | 0.040 |
Why?
|
Headache | 1 | 2008 | 1263 | 0.040 |
Why?
|
Diuretics | 1 | 2023 | 614 | 0.040 |
Why?
|
Patients | 1 | 2006 | 908 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1265 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.040 |
Why?
|
Pregnancy | 1 | 2022 | 30255 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12077 | 0.040 |
Why?
|
Flavonoids | 1 | 2003 | 447 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11878 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 1 | 2024 | 1097 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 325 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 590 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 489 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2019 | 175 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 60066 | 0.040 |
Why?
|
Models, Economic | 1 | 2021 | 719 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1232 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1157 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 714 | 0.030 |
Why?
|
Penicillins | 1 | 2019 | 406 | 0.030 |
Why?
|
Insurance | 1 | 2017 | 115 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2107 | 0.030 |
Why?
|
Prospective Payment System | 1 | 2016 | 134 | 0.030 |
Why?
|
New York | 1 | 2017 | 882 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1738 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1741 | 0.030 |
Why?
|
Piperidines | 1 | 2003 | 1667 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2009 | 3250 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2016 | 582 | 0.030 |
Why?
|
Panic Disorder | 1 | 2016 | 613 | 0.030 |
Why?
|
California | 1 | 2017 | 1438 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2914 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2003 | 3229 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1798 | 0.030 |
Why?
|
Perioperative Care | 1 | 2020 | 1043 | 0.020 |
Why?
|
Sex Distribution | 1 | 2017 | 2278 | 0.020 |
Why?
|
Societies, Medical | 1 | 2024 | 3968 | 0.020 |
Why?
|
Allergens | 1 | 2019 | 1443 | 0.020 |
Why?
|
Appointments and Schedules | 1 | 2015 | 443 | 0.020 |
Why?
|
Pyridones | 1 | 2016 | 819 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2981 | 0.020 |
Why?
|
Dyspnea | 1 | 2018 | 1352 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4034 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2055 | 0.020 |
Why?
|
Health Promotion | 1 | 2022 | 2210 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2019 | 2059 | 0.020 |
Why?
|
Labetalol | 1 | 2008 | 29 | 0.020 |
Why?
|
Sural Nerve | 1 | 2008 | 105 | 0.020 |
Why?
|
Amlodipine | 1 | 2008 | 84 | 0.020 |
Why?
|
Air Pollution | 1 | 2022 | 2374 | 0.020 |
Why?
|
Air Pollutants | 1 | 2022 | 2916 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 13013 | 0.020 |
Why?
|
Guanine | 1 | 2008 | 280 | 0.020 |
Why?
|
Hemorrhage | 1 | 2018 | 3466 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 2028 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6525 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16726 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8089 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2748 | 0.020 |
Why?
|
Child | 2 | 2022 | 80917 | 0.010 |
Why?
|
Stents | 1 | 2016 | 3197 | 0.010 |
Why?
|
Vasculitis | 1 | 2008 | 525 | 0.010 |
Why?
|
Smoking | 1 | 2021 | 9092 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8509 | 0.010 |
Why?
|
Prednisone | 1 | 2008 | 1567 | 0.010 |
Why?
|
Inflammation | 1 | 2003 | 10873 | 0.010 |
Why?
|
Hepatitis B | 1 | 2008 | 711 | 0.010 |
Why?
|
Thrombosis | 1 | 2016 | 2957 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2008 | 1375 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 89169 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 13677 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2003 | 663 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42669 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4818 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8230 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4640 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6316 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2230 | 0.010 |
Why?
|
Interleukins | 1 | 2003 | 796 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6792 | 0.010 |
Why?
|
Neoplasms | 1 | 2003 | 22371 | 0.010 |
Why?
|
Bone Marrow | 1 | 2003 | 2935 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3728 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36741 | 0.010 |
Why?
|